cas 5696-51-5|| where to buy (5R,8R,9R,10S,13S,14S)-13-Methyltetradecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione

Nom du produit:(5R,8R,9R,10S,13S,14S)-13-Methyltetradecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione

IUPAC Name:(3aS,3bR,5aR,9aS,9bR,11aS)-11a-methyl-hexadecahydro-1H-cyclopenta[a]phenanthrene-1,7-dione

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM360817-100mg	1-2 Weeks	ƻǯź

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 5696-51-5 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:5696-51-5; Formule moléculaire:C18H26O2; Point de fusion:-; Code SMILES:[H][C@@]12[C@](CCC(C3)=O)([H])[C@]3([H])CC[C@@]1([H])[C@@](CCC4=O)([H])[C@]4(C)CC2; Densité:

: Numéro de catalogue:CM360817; Poids moléculaire:274.40; Point d'ébullition:; N° Mdl:; Stockage:2-8°C

: Steroids; Naturally occurring steroids are estrogen, cortisol, progesterone, and testosterone. Pharmacologically, they are used in several ways: alter steroid metabolism via statins to help lower cholesterol; as corticosteroids to help control inflammation, asthma, and lupus; and other forms to help hormone deficiency, such as delayed puberty, as well as diseases that result in loss of lean muscle mass, such as cancer and AIDS.; Steroids Wholesale,Steroid Compounds Supplier - Chemenu; Steroids Wholesale,Steroid Compounds Supplier,Wholesale Steroids,Steriods Supplier; Chemenu is your trusted wholesale supplier of steroid compounds. Explore our wide range of wholesale steroids and choose from high-quality products for your specific needs.Experience the convenience of purchasing wholesale steroids from Chemenu and elevate your performance goals.

: Zuranolone; ZURZUVAE was approved by the FDA in August 2023 as the first-and-only oral treatment specifically indicated for adults with postpartum depression (PPD). Zuranolone is a next-generation positive allosteric modulator (PAM) of GABAA receptors being evaluated as a treatment for various affective disorders.